Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role

14 Sept 2021

Abstract excerpt

Phosphatidylinositol binding clathrin assembly protein interacting mitotic regulator (PIMREG) localizes to the nucleus and can significantly elevate the nuclear localization of clathrin assembly lymphomedullary leukocythemia gene. Although there is some evidence to support an important action for PIMREG in the occurrence and development of certain cancers, currently no pan-cancer analysis of PIMREG is available....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Galectins and Cancer Biology
Share to Phagocytosis and Immune Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34594356
DOI: 10.3389/fgene.2021.687778

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological RolePMID 34594356Read ↗

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancerSemantic proximity Read ↗

BIRC5 is a prognostic biomarker associated with tumor immune cell infiltrationSemantic proximity Read ↗

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.Semantic proximity Read ↗

Pan-cancer analysis reveals potential of RRM2 as a prognostic and immunological biomarker in human cancerSemantic proximity Read ↗

Comprehensive analysis of the prognostic value of PEBP4 in pan-cancersSemantic proximity Read ↗

Pan‐cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancersSemantic proximity Read ↗

Unveiling Biomarkers: A Study on Mitocytosis-Related Genes Across Multiple CancersSemantic proximity Read ↗

Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapySemantic proximity Read ↗

Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapySemantic proximity Read ↗

Thyroid Hormone Receptor Interacting Protein 13 Is Associated with Prognosis and Immunotherapy Efficacy in Human Cancers: A Pan-cancer AnalysisSemantic proximity Read ↗

Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types.Semantic proximity Read ↗

Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarkerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.